cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Biohaven Pharmaceutical Holding Company Ltd
8 own
14 watching
Current Price
$19.17
$0.35
(1.86%)
logo-bhvn
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,306.65M
52-Week High
52-Week High
20.57
52-Week Low
52-Week Low
5.54
Average Volume
Average Volume
1.5M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,306.65M
icon52-Week High20.57
icon52-Week Low5.54
iconAverage Volume1.5M
iconDividend Yield--
iconP/E Ratio--
What does the Biohaven Pharmaceutical Holding Company Ltd do?
N/A
Read More
How much money does Biohaven Pharmaceutical Holding Company Ltd make?
News & Events about Biohaven Pharmaceutical Holding Company Ltd.
PR Newswire
28days ago
Biohaven to Present at the 41st Annual J.P. Morgan Healthcare Conference Biohaven to Present at the 41st Annual J.P. Morgan Healthcare Conference PR Newswire NEW HAVEN, Conn., Jan. 6, 2023 NEW HAVEN, Conn., Jan. 6, 2023 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) today announced thatVlad Coric...
Globe Newswire
1month ago
Mike Heffernan appointed Chairman of NMD Pharmas Board of Directors Brings 30 years of experience building private and public development-stage and commercial biopharmaceutical companies and has overseen several successful IPOs and trade sales Aarhus, Denmark, 3 January 2023 NMD Pharma A/S, a ...
PR Newswire
3 months ago
Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares PR Newswire NEW HAVEN, Conn., Oct. 25, 2022 NEW HAVEN...
PR Newswire
3 months ago
Biohaven Announces Pricing of Public Offering of Common Shares Biohaven Announces Pricing of Public Offering of Common Shares PR Newswire NEW HAVEN, Conn., Oct. 20, 2022 NEW HAVEN, Conn., Oct. 20, 2022 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) ('Biohaven') announced today the pricing of...
Business Wire
4 months ago
Pfizer Inc. (NYSE: PFE) announced today the completion of its acquisition of Biohaven Pharmaceutical Holding Company Ltd., the maker of NURTEC ODT (rimegepant), an innovative migraine therapy approved for both acute treatment and prevention of episodic migraine in adults. The acquisition brings to...
Frequently Asked Questions
Frequently Asked Questions
What is Biohaven Pharmaceutical Holding Company Ltd share price today?
plus_minus_icon
Can Indians buy Biohaven Pharmaceutical Holding Company Ltd shares?
plus_minus_icon
How can I buy Biohaven Pharmaceutical Holding Company Ltd shares from India?
plus_minus_icon
Can Fractional shares of Biohaven Pharmaceutical Holding Company Ltd be purchased?
plus_minus_icon
What are the documents required to start investing in Biohaven Pharmaceutical Holding Company Ltd stocks?
plus_minus_icon
What is today’s traded volume of Biohaven Pharmaceutical Holding Company Ltd?
plus_minus_icon
What is today’s market capitalisation of Biohaven Pharmaceutical Holding Company Ltd?
plus_minus_icon
What is the 52-Week High and Low Range of Biohaven Pharmaceutical Holding Company Ltd?
plus_minus_icon
What percentage is Biohaven Pharmaceutical Holding Company Ltd down from its 52-Week High?
plus_minus_icon
What percentage is Biohaven Pharmaceutical Holding Company Ltd up from its 52-Week Low?
plus_minus_icon
Current Price
$19.17
$0.35
(1.86%)
logo-bhvn
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00